22
Experiences of Benchmarking and the effect of new patients Mrs Dorothy Shaw Chief BMS Stepping Hill Hospital Stockport

Experiences of Benchmarking and the effect of new patients

  • Upload
    meli

  • View
    38

  • Download
    0

Embed Size (px)

DESCRIPTION

Experiences of Benchmarking and the effect of new patients. Mrs Dorothy Shaw Chief BMS Stepping Hill Hospital Stockport. STEPPING HILL HOSPITAL. District general hospital near Manchester 815 Beds Excluding Mental Health And Maternity. Anticoagulant Service Run by Haematology. - PowerPoint PPT Presentation

Citation preview

Page 1: Experiences of Benchmarking and the effect of new patients

Experiences of Benchmarking and the effect of new patients

Mrs Dorothy ShawChief BMS

Stepping Hill HospitalStockport

Page 2: Experiences of Benchmarking and the effect of new patients

STEPPING HILL HOSPITALSTEPPING HILL HOSPITAL

District general hospital near Manchester District general hospital near Manchester

815 Beds Excluding Mental Health 815 Beds Excluding Mental Health

And MaternityAnd Maternity

Page 3: Experiences of Benchmarking and the effect of new patients

Anticoagulant Service Run by Anticoagulant Service Run by HaematologyHaematology

BMS StaffBMS Staff ChiefChief SeniorSenior Total of 5 BMS Staff who can dose at Total of 5 BMS Staff who can dose at

clinicsclinics 2 Part time MLA staff2 Part time MLA staff 3 Hospital Clinics + 10 Outreach clinics3 Hospital Clinics + 10 Outreach clinics 2670 active patients on DAWN Oct 20022670 active patients on DAWN Oct 2002

Page 4: Experiences of Benchmarking and the effect of new patients

DAWN System Purchased DAWN System Purchased Jan1999Jan1999

Joined Benchmarking At Same Joined Benchmarking At Same TimeTime

Before DAWN Audit of stable patientsBefore DAWN Audit of stable patients

60% INRs in Range60% INRs in Range

Page 5: Experiences of Benchmarking and the effect of new patients

Decision to put all available information Decision to put all available information onto dawn to aid dosing includingonto dawn to aid dosing including

a) New patientsa) New patients

AFs started in hospital outpatient clinic AFs started in hospital outpatient clinic baseline INR, 9 mg on 2 days test 3baseline INR, 9 mg on 2 days test 3rdrd day day All patients loaded in hospital, inpatient All patients loaded in hospital, inpatient dosage by hospital doctors, discharge dosage by hospital doctors, discharge dosage by laboratorydosage by laboratory

Transfers from other hospitalsTransfers from other hospitals

b) Existing patientsb) Existing patients

Dosage information from hospital stay Dosage information from hospital stay

Page 6: Experiences of Benchmarking and the effect of new patients

% INRs within 0.5 units of Target INR for April 2001 Run, Site 14 and All Ranges

0.00

10.00

20.00

30.00

40.00

50.00

60.00

70.00

80.00

90.00

100.00

% IN

Rs

This chart shows the % INRs within 0.5 units of the Target INR for all sites in ascending order.The red line across the chart shows the BSH target. Sites below the target are blue.

Sites above the target are gold. Your site is highlighted in red.

Page 7: Experiences of Benchmarking and the effect of new patients

% INRs within 0.75 units of Target INR for April 2001 Run, Site 14 and All Ranges

0.00

10.00

20.00

30.00

40.00

50.00

60.00

70.00

80.00

90.00

100.00

% IN

RS

This chart shows the % INRs within 0.75 units of the Target INR for all sites in ascending order.The red line across the chart shows the BSH target. Sites below the target are blue.

Sites above the target are gold. Your site is highlighted in red.

Page 8: Experiences of Benchmarking and the effect of new patients

% INRs within 0.5 units of Target INR for April 2001 Run, Site 14 and Range 2.50

0.00

10.00

20.00

30.00

40.00

50.00

60.00

70.00

80.00

90.00

100.00

% IN

Rs

This chart shows the % INRs within 0.5 units of the Target INR for all sites in ascending order.The red line across the chart shows the BSH target. Sites below the target are blue.

Sites above the target are gold. Your site is highlighted in red.

Page 9: Experiences of Benchmarking and the effect of new patients

% Time In Range Comparison for April 2001 Run, Site 14 and Range 2.50

0.00

10.00

20.00

30.00

40.00

50.00

60.00

70.00

80.00

90.00

100.00

% T

ime

In R

ange

This chart shows the time in range for all sites in ascending order.The bar below the line shows the time below range; the bar above the line shows the time above range.

Your site is highlighted in red.

Page 10: Experiences of Benchmarking and the effect of new patients

Benchmarking Run: April 2001Participating Site: 14Target INR Range: 2.50

Your Site – Split by Weeks from Start of Treatment

Weeks TherapyAll 1 - 3 4 - 9 10 - 21 22+

Number of patients 2360 398 413 444 1958

Number of INRs 16292 2018 1265 1433 11576

% Time in range (Rosendaal) 66.49 40.28 49.60 59.88 69.06

% Time above range (Rosendaal) 15.92 19.88 11.51 14.52 16.18

% Time below range (Rosendaal) 17.59 39.83 38.90 25.60 14.76

% Time in 2.0-4.4 (Rosendaal) 81.00 55.93 59.55 72.87 83.95

% Time in range (Duxbury) 63.76 40.75 47.87 56.16 65.81

Mean % Time in Range (Rosendaal) 64.68 39.69 47.53 56.69 69.17

SD % Time in Range (Rosendaal) 26.13 27.54 33.32 32.81 24.82

% INRs in range 52.88 35.23 44.07 49.57 57.89

% INRs above range 18.87 17.52 12.89 16.50 20.16

% INRs below range 28.26 47.25 43.04 33.93 21.95

% INRs within 0.5 units of target 52.88 35.23 44.07 49.57 57.89

% INRs within 0.75 units of target 67.43 48.42 59.88 66.30 72.29

% INRs > 5 2.07 3.62 1.72 2.42 1.76

% INRs < 1.3 4.29 17.92 3.44 3.44 1.77

Page 11: Experiences of Benchmarking and the effect of new patients

BENCHMARKING BENCHMARKING

Monitoring of performanceMonitoring of performance site - site comparisonsite - site comparison BSH guidelinesBSH guidelines internal auditinternal audit

Page 12: Experiences of Benchmarking and the effect of new patients

OUTSIDE INFLUENCESOUTSIDE INFLUENCES

Afs started in hospital clinic baseline INR Afs started in hospital clinic baseline INR and loading doses recorded onto and loading doses recorded onto commentscomments

Start with INR on 3rd dayStart with INR on 3rd day record inpatient doses onto commentsrecord inpatient doses onto comments record information from transfers onto record information from transfers onto

commentscomments

Page 13: Experiences of Benchmarking and the effect of new patients

RESULTING IN RESULTING IN

Information on DAWN related only to inrs Information on DAWN related only to inrs and dosages done in anticoagulant clinicand dosages done in anticoagulant clinic

Page 14: Experiences of Benchmarking and the effect of new patients

% INRs within 0.5 units of Target INR for April 2002 Run, Site 14 and All Ranges

0.00

10.00

20.00

30.00

40.00

50.00

60.00

70.00

80.00

90.00

100.00

% IN

Rs

This chart shows the % INRs within 0.5 units of the Target INR for all sites in ascending order.The red line across the chart shows the BSH target. Sites below the target are blue.

Sites above the target are gold. Your site is highlighted in red.

Page 15: Experiences of Benchmarking and the effect of new patients

% INRs within 0.75 units of Target INR for April 2002 Run, Site 14 and All Ranges

0.00

10.00

20.00

30.00

40.00

50.00

60.00

70.00

80.00

90.00

100.00

% IN

RS

This chart shows the % INRs within 0.75 units of the Target INR for all sites in ascending order.The red line across the chart shows the BSH target. Sites below the target are blue.

Sites above the target are gold. Your site is highlighted in red.

Page 16: Experiences of Benchmarking and the effect of new patients

% INRs within 0.5 units of Target INR for April 2002 Run, Site 14 and Range 2.50

0.00

10.00

20.00

30.00

40.00

50.00

60.00

70.00

80.00

90.00

100.00

% IN

Rs

This chart shows the % INRs within 0.5 units of the Target INR for all sites in ascending order.The red line across the chart shows the BSH target. Sites below the target are blue.

Sites above the target are gold. Your site is highlighted in red.

Page 17: Experiences of Benchmarking and the effect of new patients

% INRs within 0.75 units of Target INR for April 2002 Run, Site 14 and Range 2.50

0.00

10.00

20.00

30.00

40.00

50.00

60.00

70.00

80.00

90.00

100.00

% IN

RS

This chart shows the % INRs within 0.75 units of the Target INR for all sites in ascending order.The red line across the chart shows the BSH target. Sites below the target are blue.

Sites above the target are gold. Your site is highlighted in red.

Page 18: Experiences of Benchmarking and the effect of new patients

% Time In Range Comparison for April 2002 Run, Site 14 and Range 2.50

1972

1057

1576

5283

1055

1989

1161

149

899

262

1468

5481

2432

2225

93 810

1744

1234

2230

994

1619

1231

1566

2393

1287

2875

2764

1559

1171

1027

618

1758

826

748

2282

1845

1784

371

225

1781

2906

913

357

851

1245

1525

1374

1478

2533

2418

1473

0.00

10.00

20.00

30.00

40.00

50.00

60.00

70.00

80.00

90.00

100.00

% T

ime

In R

ang

e

This chart shows the time in range for all sites in ascending order.The bar below the line shows the time below range; the bar above the line shows the time above range.

Your site is highlighted in red. The numbers of patients for each site are shown at the bottom of the chart.

Page 19: Experiences of Benchmarking and the effect of new patients

Benchmarking Run: April 2002Participating Site: 14Target INR Range: 2.50

Your Site – Split by Weeks from Start of Treatment

Weeks TherapyAll 1 - 3 4 - 9 10 - 21 22+

Number of patients 2418 361 416 428 2024

Number of INRs 14081 832 1171 1226 10852

% Time in range (Rosendaal) 76.35 52.13 57.00 68.46 78.39

% Time above range (Rosendaal) 8.82 16.08 6.70 6.80 8.93

% Time below range (Rosendaal) 14.83 31.79 36.31 24.75 12.68

% Time in 2.0-4.4 (Rosendaal) 84.37 65.21 62.96 74.54 86.54

% Time in range (Duxbury) 73.64 52.82 55.38 67.29 75.20

Mean % Time in Range (Rosendaal) 73.04 50.86 53.80 64.14 76.66

SD % Time in Range (Rosendaal) 25.34 35.86 34.75 34.35 23.57

% INRs in range 63.33 51.42 48.67 59.26 66.56

% INRs above range 12.87 19.28 9.66 8.66 13.18

% INRs below range 23.80 29.30 41.67 32.07 20.27

% INRs within 0.5 units of target 60.83 48.70 47.35 57.70 63.83

% INRs within 0.75 units of target 75.35 63.91 65.25 73.55 77.74

% INRs > 5 1.40 2.72 0.85 0.92 1.40

% INRs < 1.3 1.17 2.10 1.99 1.57 0.94

Page 20: Experiences of Benchmarking and the effect of new patients

Benchmarking Run: April 2002Participating Site: 14Target INR Range: 2.50

Your Site – Comparison with Previous Runs

This Run Last Run But 1

Number of patients 2418 2360

Number of INRs 14081 16292

% Time in range (Rosendaal) 76.35 66.49

% Time above range (Rosendaal) 8.82 15.92

% Time below range (Rosendaal) 14.83 17.59

% Time in 2.0-4.4 (Rosendaal) 84.37 81.00

% Time in range (Duxbury) 73.64 63.76

Mean % Time in Range (Rosendaal) 73.04 64.68

SD % Time in Range (Rosendaal) 25.34 26.13

% INRs in range 63.33 52.88

% INRs above range 12.87 18.87

% INRs below range 23.80 28.26

% INRs within 0.5 units of target 60.83 52.88

% INRs within 0.75 units of target 75.35 67.43

% INRs > 5 1.40 2.07

% INRs < 1.3 1.17 4.29

Page 21: Experiences of Benchmarking and the effect of new patients

Comparison for new patients Comparison for new patients weeks therapy 1 -3weeks therapy 1 -3

April 2001 April 2002April 2001 April 2002 no of pts 398 361no of pts 398 361 no of INRs 2018 832no of INRs 2018 832 % time in range 40.28 52.13% time in range 40.28 52.13 % INRs in range 35.23 51.42% INRs in range 35.23 51.42 % INRs below range 47.25 29.30% INRs below range 47.25 29.30 % INRs > 5 3.62 2.72% INRs > 5 3.62 2.72 % INRs <1.3 17.92 2.10 % INRs <1.3 17.92 2.10

Page 22: Experiences of Benchmarking and the effect of new patients

CONCLUSIONSCONCLUSIONS

Monitoring of clinic performanceMonitoring of clinic performance Hospital and outreach clinicsHospital and outreach clinics disregard other influencesdisregard other influences improve performance in appropriate INR improve performance in appropriate INR

rangesranges Internal audit - Inpatient dosing auditInternal audit - Inpatient dosing audit Dawn is working well in the clinicDawn is working well in the clinic